Mylan Gets OK for Prilosec Equivalent
From Reuters
Mylan Laboratories Inc. said regulators approved its application for a generic version of heartburn drug Prilosec. The Food and Drug Administration approved Mylan’s application for delayed-release 10-milligram and 20-milligram versions of the drug, and gave tentative approval to the 40-milligram version.
It was unclear when Mylan would launch its version of the drug. AstraZeneca, which makes Prilosec, has sued Mylan and other potential generic competitors.
